BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6324330)

  • 1. Effects of treatment compliance and overnight gastric secretion on outcome of maintenance therapy of duodenal ulcer with ranitidine.
    Boyd EJ; Wilson JA; Wormsley KG
    Scand J Gastroenterol; 1983 Mar; 18(2):193-200. PubMed ID: 6324330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety of ranitidine maintenance treatment of duodenal ulcer.
    Boyd EJ; Wilson JA; Wormsley KG
    Scand J Gastroenterol; 1984 May; 19(3):394-400. PubMed ID: 6330871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of fasting on 24-h gastric secretion of patients with duodenal ulcers resistant to ranitidine.
    Johnston DA; Wormsley KG
    Aliment Pharmacol Ther; 1989 Oct; 3(5):471-9. PubMed ID: 2518860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized study of maintenance therapy with ranitidine to prevent the recurrence of duodenal ulcer.
    Van Deventer GM; Elashoff JD; Reedy TJ; Schneidman D; Walsh JH
    N Engl J Med; 1989 Apr; 320(17):1113-9. PubMed ID: 2651924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time of administration influences gastric inhibitory effects of ranitidine.
    Johnston DA; Wormsley KG
    Scand J Gastroenterol; 1988 Nov; 23(9):1137-40. PubMed ID: 3247592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ranitidine: prophylaxis of duodenal ulcer recurrence.
    Lee FI; Fielding JD; Holmes GK; Hine KR; Gibson JA; Lochee-Bayne E; Mackay C; Mitchell KG; Pickard WR; Orchard RT
    Hepatogastroenterology; 1984 Apr; 31(2):85-7. PubMed ID: 6327479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Asymptomatic duodenal ulcers occurring during maintenance treatment with ranitidine.
    Penston JG; Wormsley KG
    Aliment Pharmacol Ther; 1990 Dec; 4(6):569-76. PubMed ID: 2129644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seasonal behaviour of healed duodenal ulcer.
    Gupta AK; Pal LS
    J Indian Med Assoc; 1998 Apr; 96(4):106-8. PubMed ID: 9844330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ranitidine in the prevention of gastric and duodenal ulcer relapse.
    Alstead EM; Ryan FP; Holdsworth CD; Ashton MG; Moore M
    Gut; 1983 May; 24(5):418-20. PubMed ID: 6301956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does maintenance therapy keep duodenal ulcers healed?
    Boyd EJ; Penston JG; Johnston DA; Wormsley KG
    Lancet; 1988 Jun; 1(8598):1324-7. PubMed ID: 2897568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ranitidine, cimetidine and antacids in the prevention of recurrence after healed duodenal ulcer: one-year experience.
    Bresci G; Capria A; Rindi G; Geloni M; Federici G; Corsini G
    Int J Tissue React; 1983; 5(4):345-8. PubMed ID: 6323335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Does nocturnal monitoring of gastric pH permit the prediction of therapeutic response in severe duodenal ulcer treated with ranitidine?].
    Galmiche JP; Tranvouez JL; Denis P; N'Djitoyap C; Guillard JF; Lehur PA; Colin R
    Gastroenterol Clin Biol; 1985; 9(8-9):583-9. PubMed ID: 4076717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of bedtime ranitidine on overnight gastric acid output and intragastric pH: dose/response study and comparison with cimetidine.
    Chambers JB; Pryce D; Bland JM; Northfield TC
    Gut; 1987 Mar; 28(3):294-9. PubMed ID: 3570035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of H2-receptor blockade by ranitidine on ulcer healing and gastric acid secretion in patients with gastric and duodenal ulcers.
    Forssell H; Koch G
    Eur J Clin Pharmacol; 1983; 25(2):195-8. PubMed ID: 6313376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of eight weeks' continuous treatment with oral ranitidine and cimetidine on gastric acid secretion, pepsin secretion, and fasting serum gastrin.
    Mohammed R; Holden RJ; Hearns JB; McKibben BM; Buchanan KD; Crean GP
    Gut; 1983 Jan; 24(1):61-6. PubMed ID: 6129180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review of peptic ulcer maintenance trials.
    Robinson M
    Am J Med; 1984 Nov; 77(5B):23-9. PubMed ID: 6095657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acid secretory changes and early relapse following duodenal ulcer healing with ranitidine or sucralfate.
    Marks IN; Johnston DA; Young GO
    Am J Med; 1991 Aug; 91(2A):95S-101S. PubMed ID: 1882911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ranitidine maintenance therapy in the prevention of duodenal ulceration; a comparison of 150 mg at night with 300 mg at night.
    McDougle AM; Lancaster-Smith MJ; Higson DL
    Aliment Pharmacol Ther; 1995 Jun; 9(3):287-91. PubMed ID: 7654891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ranitidine and cimetidine in prevention of duodenal ulcer relapse. A double-blind, randomised, multicentre, comparative trial.
    Gough KR; Korman MG; Bardhan KD; Lee FI; Crowe JP; Reed PI; Smith RN
    Lancet; 1984 Sep; 2(8404):659-62. PubMed ID: 6147693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is the inhibition of nocturnal gastric acid secretion the most important factor in duodenal ulcer treatment? A comparison between the effectiveness of single morning and nocte doses of ranitidine 300 mg.
    Zaterka S; Massuda HK; Eisig JN; Chinzon D; Bettarello A
    Rev Hosp Clin Fac Med Sao Paulo; 1989; 44(5):185-8. PubMed ID: 2700103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.